Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I Study of FID-007 in Patients With Advanced Solid Tumors

NCT03537690 is registered in ClinicalTrials.gov with University of Southern California as lead sponsor.

NCT NCT03537690
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03537690 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I Study of FID-007 in Patients With Advanced Solid Tumors
Lead sponsor
University of Southern California
Phase
Phase 1
Overall status
Active, not recruiting
Start date
May 25, 2018
Completion date
May 25, 2027
Enrollment
50 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

advanced malignant solid neoplasm, refractory malignant solid neoplasm